New supplement shows promise for diabetic eye damage

NCT ID NCT04552600

First seen Jan 04, 2026 · Last updated May 13, 2026 · Updated 18 times

Summary

This study tested a natural supplement called Nuvastatic in 100 adults with type 2 diabetes who have early-stage diabetic retinopathy (eye damage) without swelling in the central vision area. The goal was to see if it can safely slow the disease and improve vision by reducing inflammation and protecting blood vessels. Participants took the supplement or a placebo for several months, and researchers measured changes in retinal thickness, visual sharpness, and protein markers in the eye.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Fifepoint Multispeciality Hospital Pvt. Ltd.

    Pune, Maharashtra, 411057, India

Conditions

Explore the condition pages connected to this study.